$797.99+10.85% · 3M
Moving avg
1W+3.83%
1M+20.34%
3M+10.85%
6M+2.44%
YTD+2.79%
1Y+43.38%
3Y-1.29%
5Y+31.25%
52-week range
$541.0092% of range$821.11
Company health
Value4/6
Growth6/6
Profitability6/6
Health6/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Strong 31% net margin
- High return on equity (1432%)
- Revenue compounding 16% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$82.21B
Enterprise value
$67.33B
P/E ratio (TTM)
15.42x
P/S ratio (TTM)
4.53x
EV/EBITDA
11.72x
Per share & returns
EPS (TTM)
$42.53
Dividend yield
0.55%
Beta (1Y)
0.24
30-day change
+20.34%
Trading
Volume (24h)
474.88K
Previous close
$797.00
Shares outstanding
103.02M
About Regeneron Pharmaceuticals, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
REGN
Regeneron Pharmaceuticals, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker REGN.
Frequently asked questions
What is Regeneron Pharmaceuticals, Inc.'s market cap?
Regeneron Pharmaceuticals, Inc. (REGN) has a market capitalization of $82.21B.
What is Regeneron Pharmaceuticals, Inc.'s P/E ratio?
Regeneron Pharmaceuticals, Inc. trades at a price-to-earnings (P/E) ratio of 15.42.
What exchange does REGN trade on?
REGN trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.40-0.57%
$355.97B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.90-0.24%
$289.80B cap
AstraZeneca PLCLON: AZN
£116.68-0.29%
$244.11B cap